Ponesimod Compared with Teriflunomide in Patients with Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study: A Randomized Clinical Trial

Ludwig Kappos, Robert J. Fox, Michel Burcklen, Mark S. Freedman, Eva K. Havrdová, Brian Hennessy, Reinhard Hohlfeld, Fred Lublin, Xavier Montalban, Carlo Pozzilli, Tatiana Scherz, Daniele D'Ambrosio, Philippe Linscheid, Andrea Vaclavkova, Magdalena Pirozek-Lawniczek, Hilke Kracker, Till Sprenger

Publikation: Beitrag in FachzeitschriftArtikelBegutachtung

148 Zitate (Scopus)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Ponesimod Compared with Teriflunomide in Patients with Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study: A Randomized Clinical Trial“. Zusammen bilden sie einen einzigartigen Fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science